US Stock MarketDetailed Quotes

MINDMAZE THERAPEUTICS HOLDING SA SPON ADS EACH REP 1 ORD SHS (RLFTY)

Watchlist
  • 0.4225
  • -1.3103-75.62%
15min DelayClose Jun 1 11:16 ET
64.47MMarket Cap-0.69P/E (TTM)

MINDMAZE THERAPEUTICS HOLDING SA SPON ADS EACH REP 1 ORD SHS (RLFTY) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2.92M
Net income from continuing operations
-990,500.00%-9.91M
---1K
Operating gains losses
----
---1.45M
Depreciation and amortization
----
--2.56M
Deferred tax
----
---2.24M
Other non cash items
-1,700.00%-36K
---2K
Change In working capital
--844K
--0
-Change in receivables
---287K
--0
-Change in inventory
----
---485K
-Change in payables and accrued expense
----
---424K
-Change in other current assets
---203K
--0
-Change in other working capital
----
--2.39M
Cash from discontinued investing activities
Operating cash flow
-240,166.67%-7.21M
---3K
Investing cash flow
Cash flow from continuing investing activities
4.4M
Net PPE purchase and sale
---22K
--0
Net intangibles purchase and sale
----
--4.22M
Net business purchase and sale
--9.57M
--0
Net investment purchase and sale
--0
---2K
Net other investing changes
---6.22M
----
Cash from discontinued investing activities
Investing cash flow
182,300.00%3.64M
---2K
Financing cash flow
Cash flow from continuing financing activities
-862K
Net issuance payments of debt
----
---862K
Net common stock issuance
----
--0
Net other financing activities
--13.28M
----
Cash from discontinued financing activities
Financing cash flow
--13.01M
--0
Net cash flow
Beginning cash position
--0
--5K
Current changes in cash
189,060.00%9.45M
---5K
Effect of exchange rate changes
--25K
--0
End cash Position
--9.47M
--0
Free cash flow
-240,900.00%-7.23M
---3K
Currency Unit
CHF
CHF
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
(FY)Dec 31, 2025(FY)Dec 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2.92M
Net income from continuing operations -990,500.00%-9.91M---1K
Operating gains losses -------1.45M
Depreciation and amortization ------2.56M
Deferred tax -------2.24M
Other non cash items -1,700.00%-36K---2K
Change In working capital --844K--0
-Change in receivables ---287K--0
-Change in inventory -------485K
-Change in payables and accrued expense -------424K
-Change in other current assets ---203K--0
-Change in other working capital ------2.39M
Cash from discontinued investing activities
Operating cash flow -240,166.67%-7.21M---3K
Investing cash flow
Cash flow from continuing investing activities 4.4M
Net PPE purchase and sale ---22K--0
Net intangibles purchase and sale ------4.22M
Net business purchase and sale --9.57M--0
Net investment purchase and sale --0---2K
Net other investing changes ---6.22M----
Cash from discontinued investing activities
Investing cash flow 182,300.00%3.64M---2K
Financing cash flow
Cash flow from continuing financing activities -862K
Net issuance payments of debt -------862K
Net common stock issuance ------0
Net other financing activities --13.28M----
Cash from discontinued financing activities
Financing cash flow --13.01M--0
Net cash flow
Beginning cash position --0--5K
Current changes in cash 189,060.00%9.45M---5K
Effect of exchange rate changes --25K--0
End cash Position --9.47M--0
Free cash flow -240,900.00%-7.23M---3K
Currency Unit CHFCHF
Audit Opinions --Unqualified Opinion with Explanatory Notes
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 1 Eastern Time, Middle East geopolitics took a dramatic turn. Iran's Tasnim News Agency reported that, in light of Israel’s ongoing Show More